Metabolic-immune crosstalk in head and neck squamous cell carcinoma: CD44 and APP identified as causal therapeutic targets via integrated lactylation-Mendelian randomization analysis.
Saved in:
| Title: | Metabolic-immune crosstalk in head and neck squamous cell carcinoma: CD44 and APP identified as causal therapeutic targets via integrated lactylation-Mendelian randomization analysis. |
|---|---|
| Authors: | Zhang X; Department of Otolaryngology Head and Neck Surgery, Beijing Anzhen Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China., Deng Q; Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China., Yang L; Department of Otolaryngology Head and Neck Surgery, Dazhou Central Hospital, Dazhou, Sichuan, China., Yan M; Beijing Anzhen Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 May 28; Vol. 17, pp. 1808455. Date of Electronic Publication: 2026 May 28 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1808455 |
